We are live on ! Find out more
BGMS

Bio Green Med Solution Inc
BGMS

21 hedge funds and large institutions have $1.29M invested in Bio Green Med Solution Inc in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

13% less funds holding

Funds holding: 24 → 21 (-3)

21% less capital invested

Capital invested by funds: $1.63M → $1.29M (-$348K)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
6
Closed
4
Calls
$14K
Puts
–
Net Calls
+$14K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$227K
2
Osaic Holdings
Osaic Holdings
Arizona
+$2.98K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$74.5K
2
SSA
Schonfeld Strategic Advisors
New York
-$29.8K
3
E
Ergoteles
New York
-$17.3K
4
VF
Virtu Financial
New York
-$16K
5
HF
HRT Financial
New York
-$14.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
1
Schonfeld Strategic Advisors
New York
$420K -$29.8K -10 -5%
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$206K – – –
SFM
3
Sphera Funds Management
Israel
$143K – – –
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$131K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$97K – – –
Millennium Management
6
Millennium Management
New York
$68K -$74.5K -25 -43%
Vanguard Group
7
Vanguard Group
Pennsylvania
$49.6K – – –
BCM
8
Bridgeway Capital Management
Texas
$36.8K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$35.4K – – –
ME
10
McIlrath & Eck
Washington
$15K – – –
Two Sigma Investments
11
Two Sigma Investments
New York
$12.5K -$2.98K -1 -14%
HF
12
HRT Financial
New York
$12K -$14.9K -5 -45%
RJFSA
13
Raymond James Financial Services Advisors
Florida
$11.9K – – –
IC
14
Ikarian Capital
Texas
$11K +$227K +76 New
Northern Trust
15
Northern Trust
Illinois
$8.53K – – –
Osaic Holdings
16
Osaic Holdings
Arizona
$7.47K +$2.98K +1 +33%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$6.79K -$5.96K -2 -40%
State Street
18
State Street
Massachusetts
$6.03K – – –
BlackRock
19
BlackRock
New York
$2.68K – – –
Citadel Advisors
20
Citadel Advisors
Florida
$2.59K -$11.9K -4 -80%
TRCT
21
Tower Research Capital (TRC)
New York
$2K – – –
Morgan Stanley
22
Morgan Stanley
New York
$685 – – –
Wells Fargo
23
Wells Fargo
California
$328 – – –
S
24
SignatureFD
Georgia
$171 – – –
E
25
Ergoteles
New York
– -$17.3K -7 Closed
1
2

BGMS Hedge Fund Activity: Q1 2023 in Review

21 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc (BGMS) for Q1 2023, worth a combined $1.29M — down 21% from $1.63M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BGMS and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $227K. The largest seller was Millennium Management, cutting an estimated $74.5K.

  • 21 institutional investors held Bio Green Med Solution Inc (BGMS) as of Q1 2023, down from 24 in Q4 2022.
  • Funds reported $1.29M of Bio Green Med Solution Inc stock for Q1 2023, down 21% quarter-over-quarter.
  • 1 fund opened new Bio Green Med Solution Inc positions in Q1 2023 and 4 closed out, a net change of -3 holders.
  • The largest Bio Green Med Solution Inc buyer in Q1 2023 was Ikarian Capital, an estimated $227K added.
  • The largest Bio Green Med Solution Inc seller in Q1 2023 was Millennium Management, an estimated $74.5K sold.

Based on aggregated 13F filings for Q1 2023.